Drug Approval | September 21, 2023
Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%
Clindamycin Phosphate Gel is used to treat acne
Clindamycin Phosphate Gel is used to treat acne
Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day had annual sales of US $330 million in the United States
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)
Diclofenac Sodium and Misoprostol Delayed Release Tablets USP, 50mg/200 mcg and 75mg/200 mcg had annual sales of USD 13 mn in the United States
Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg had annual sales of USD 42 mn in the United States (IQVIA MAT April 2023)
Tadalafil Tablets USP, 20 mg had annual sales of USD 61 mn in the United States (IQVIA MAT April 2023)
Ephedrine Sulfate Injection USP, 50 mg/mL had annual sales of USD 52 mn in the United States
Subscribe To Our Newsletter & Stay Updated
